Labeling and tracking the mobility of double-stranded breaks
To generate, track, and quantify the mobility of a single-irreparable DSB we modified the well-characterized strain JKM179, in which a single site-specific cut in the MAT locus on chromosome III is induced by a galactose-regulated HO-endonuclease gene (Gal-HO) [15]. To visualize and track the DSB, we monitored the DNA damage checkpoint protein Ddc2 (Ddc2-GFP) which we have previously shown forms a damage-dependent GFP focus in ~ 80% of cells 3 h after adding galactose [13]. An mCherry-tagged spindle pole body protein Spc42 (Spc42-mCherry) was used as a fiducial marker to account for random nuclear motion. Cutting by Gal-HO is highly efficient with nearly 90% of cells being cleaved 1 h after galactose addition [15–17]. In these strains the homologous HML and HMR donors are deleted, thus preventing repair of MAT by HR. When HO is continually expressed, repair of the DSB by altering the cleavage site via nonhomologous end-joining occurs in only 0.2% of cells [18]. We measured DSB mobility 3 h after adding galactose and quantified the mobility of the DSB using mean-squared displacement (MSD) analysis (see Methods for details) (Fig. 1A-B).
Blocking Arp2/3 activity lowers DSB mobility
To test whether Arp2/3 activity has a conserved role in DSB mobility in budding yeast, we added 10µM CK-666 to block Arp2/3 activity 20 min before imaging (160 min after adding galactose) (Fig. 1C). Addition of CK-666 significantly lowered the radius of confinement (Rc) of the DSB from 0.92 µm to 0.69 µm (Fig. 1B and Table S1). Addition of CK-666 did not affect the mobility of the spindle pole bodies relative to the bud neck (Figure S1A-B, Table S1), suggesting that the changes seen in DSB mobility when cells are treated with CK-666 were due to the changes in the behavior of the DSB.
Since Arp2/3 is primarily known as a component of endocytosis in budding yeast, we asked whether the change in DSB mobility was due to impaired endocytosis. Deletion of SLA2, a key component of endocytosis [19], did not affect the behavior of the DSB (Fig. 1D-E and Table S1). This result suggests that endocytosis is not required for DSB mobility and that the role of Arp2/3 in DSB mobility is independent of its role in endocytosis.
Arp2/3 affects changes in local and global chromatin mobility in response to a DSB
While the direct labeling of DSBs with Ddc2-GFP is suitable for tracking the mobility of DSBs, it cannot be used to establish a basal level of chromatin mobility in the absence of a DSB. To test whether Arp2/3 is required for increasing chromatin mobility near a DSB, we induced an irreparable DSB at MAT in a derivative of strain JKM179 that expresses the GFP-LacI protein that binds to a lacO array inserted 4.4 kb away from the MAT locus [20] (Fig. 2A). As previously reported [20], we found that inducing a DSB caused an increase in local chromatin mobility near the DSB site: RC 0.63 µm (uncut) and 1.1 µm (cut) (Fig. 1B, G and Table S1). CK-666 did not significantly affect basal levels of chromatin mobility: Rc uncut (0.63 µm) and uncut + CK-666 (0.54 µm) (Fig. 1B, G and Table S1); however, treatment with CK-666 either 20 min before (Fig. 2C) or 160 min after (Fig. 2E) DSB induction resulted in no increase in DSB mobility compared with the uncut condition, monitored at 180 min (Fig. 2D, F-G and Table S1). Thus, CK-666 impairs DSB-induced chromatin mobility.
Nucleation promoting factors are required DSB-induced increase in mobility
In humans, Arp2/3 requires the NPF WASP to nucleate new branches of actin [9, 10]; Las17 is the budding yeast homologue of WASP (Fig. 3A) [21]. To test whether Las17 was required for DSB mobility, we added an auxin-inducible degron (AID) to the C-terminus of Las17 (Las17-AID) [22, 23]. Adding 1mM auxin (IAA) caused degradation of Lad17-AID within 1h (Fig. 3B). The AID-tag did not affect the MSD curve of Las17-AID, but when IAA was added 2 h after Gal-HO induction, the mobility of the DSB measured at 3 h dropped: Rc WT (0.83 µm), Las17-AID (0.77 µm), and Las17-AID + IAA (0.49 µm) (Fig. 3C-D, Table S1).
To further characterize the role of Las17, we deleted functional domains that are responsible for Arp2/3 activation. Deletion of the acidic patch (CA) domain (las17-CA∆), which directly binds to Arp2/3 to activate Arp2/3 [24], did not result in a significant change in the mobility of the DSB: Rc WT (0.91 µm) and las17-CA∆ (0.90 µm) (Fig. 3E-F, Table S1). However, additional deletion of the WH2 domain, which brings monomeric actin to Arp2/3, along with the CA domain (las17-WH2-CAΔ) lowered the mobility of the DSBs: RC las17-WH2-CAΔ (0.53 µm) (Fig. 3E-F, Table S1). This suggests that Las17 in its role as an Arp2/3 actin nucleator is required for DSB mobility.
The type-I myosins Myo3 and Myo5 play a role in DSB mobility
Type-I myosins Myo3 and Myo5 promote actin nucleation by Arp2/3 during endocytosis in budding yeast [25] and depletion of Myo1a and Myo1b in Drosophilia increases sensitivity to ionizing radiation [6]. We asked if Myo3 or Myo5 have a role in DSB mobility in budding yeast. We found that a single deletion of MYO3 or MYO5 was sufficient to lower the mobility of the DSB: Rc WT (0.83 µm), myo3∆ (0.60 µm), and myo5∆ (0.58 µm) (Fig. 4A, C and Table S1). The effect of deleting either type-I myosin was different from what is seen in endocytosis, where Myo3 and Myo5 are functionally redundant [26]. We then asked whether a second copy of one type-I myosin, added to a deletion of the other, would restore DSB mobility. We integrated a second copy of MYO5 at URA3 on chromosome V, under control of its own promoter, in a myo3Δ background and found that there was no significant difference in the Rc between the WT (0.83 µm) and the myo3Δ Myo5 (+ Myo5) (0.80 µm) strains. (Fig. 4B-C, Table S1).
To determine which functional domains of Myo5 are required for DSB mobility, we integrated a series of MYO5 domain deletion plasmids with their endogenous promotors [25] into a myo5D strain. In the presence of Myo3, we found that there was no significant difference in the RC between the wildtype strain and a deletion of the Myo5 motor-domain, TH1, or TH2 domains: WT (0.89 µm), myo5-motorΔ (0.86µm), myo5-TH1Δ (0.85 µm), and myo5-TH2Δ (0.96 µm) (Figure S2A-C, E and Table S1). However, a deletion of the SH3 domain (myo5-SH3Δ) did not restore the mobility of the DSBs back to wildtype levels; RC WT (0.89 µm) and myo5-SH3Δ (0.62 µm) (Figure S2D-E, Table S1).
Because a double deletion of MYO3 and MYO5 is synthetically lethal in most backgrounds [27, 28], we added an AID tag to Myo5 (Myo5-AID) in a myo3D strain. In a MYO3 strain, the addition of the AID tag to Myo5 did not affect the mobility of the DSB and adding IAA 2 h after DSB induction reduced mobility, similar to the MYO5 deletion. (Figure S3, Table S1). Unexpectedly, in the myo3∆ Myo5-AID strain, treatment with IAA increased the mobility of the DSB to near WT levels: Rc WT (0.81 µm), myo3∆ Myo5-AID (0.6 µm), and myo3∆ Myo5-AID + IAA (0. 81 µm) (Fig. 4D-E, Table S1).
Since Las17 has a WH2 domain and acidic (CA) patch, it is possible that the increase in DSB mobility when both Myo3 and Myo5 are absent could be due to the Arp2/3 actin nucleation by Las17. To test this, we deleted the WH2 and CA domains of Las17 (las17-WH2-CAΔ) in a myo3Δ Myo5-AID background and measured the mobility of the DSB ± IAA as described above. We found that the las17 mutant prevented the restoration of Rc to WT levels that was seen when both Myo3 and Myo5 are inactivated: Rc WT (0.99 µm), myo3Δ Myo5-AID las17-WH2-CAΔ (0.57 µm), and myo3Δ Myo5-AID las17-WH2-CAΔ + IAA (0.58 µm) (Figure S4, Table S1). Together these results suggest that Myo3 and Myo5 in their role as Arp2/3 actin nucleators play a role in DSB mobility and Las17 can compensate for the loss of both Myo3 and Myo5 to maintain near WT levels of DSB mobility.
Arp2/3 and myosins are required for damage-dependent focus formation with Ddc2-GFP or Rad51-GFP
Ddc2-GFP and Rad51-GFP form damage-dependent foci in ≥ 80% of cells 3 h after DSB induction [13]. However, when Arp2/3 activity was blocked by CK-666 before DSB induction, we observed that Ddc2-GFP and Rad51-GFP formed foci in fewer than 15% of cells (Figure S5A-B). Similar inhibition of the DSB-induced foci was found in a deletion of VRP1, or when IAA was added to Las17-AID or myo3Δ Myo5-AID cultures. Deletion of KU70 did not restore damage-dependent Ddc2-GFP foci formation in CK-666 treated cells (Figure S5C). This finding raised the possibility that blocking Arp2/3 might interfere with either Gal-HO cutting or with long-range resection. By using a pair of PCR primers that flank the HO-cut site in the MAT locus (Figure S5A) we showed that Gal-HO cutting was unaffected in Las17-AID or myo3∆ Myo5-AID mutants treated 1 h before DSB induction with IAA (Figure S5B-D).
Arp2/3 and type-I myosins are required for the initiation and maintenance of resection
Since Gal-HO cutting is normal, blocking Arp2/3 activity might interfere with 5’ to 3’ resection of the DSB. We first monitored the disappearance of GFP-LacI/lacO foci in a strain where the lacO array was inserted 4.4 kb away from the HO cleavage site at MAT (Fig. 2A). As resection erodes the lacO array, GFP-LacI will lose its binding sites and the GFP-LacI/lacO focus will vanish. Within 2 h after DSB induction there was a steady drop in the percentage of cells with a GFP-LacI focus (Fig. 5A). However, addition of CK-666 1 h before HO induction prevented the loss of the GFP-LacI focus. Resection in cells treated with CK-666 after 1 h after DSB induction was also significantly impaired.
We used a restriction enzyme-based qPCR resection assay to measure the generation of ssDNA around the HO-cut site itself [29, 30]. qPCR analysis was done using a series of primers flanking STY1 cut sites at different distances from the HO-cut site in the MAT locus (0.7 kb, 5 kb, and 10 kb) (Fig. 5B). As resection converts dsDNA to ssDNA, StyI cleavage sites are lost and qPCR threshold signal is detected.
We measured resection in Las17-AID, myo3∆, myo5∆, and myo3Δ Myo5-AID mutants. IAA was added either 1 h before or 2 h after adding galactose. Las17-AID without IAA had a similar resection profile as the wildtype; however, when IAA was added either before or after galactose, long range resection was severely impaired (Fig. 5C) suggesting that Las17 is required for the initiation and maintenance of resection.
Single deletions of MYO3 or MYO5 did not greatly affect resection (Fig. 5D). Resection in the myo3∆ Myo5-AID mutant without IAA was comparable to resection in the WT, as expected from the myo3∆ resection data (Fig. 5D-E); but when IAA was added to myo3∆ Myo5-AID 1 h before DSB induction, there was little to no resection up to 6 h after DSB induction (Fig. 5E). Finally, when IAA was added 2 h after DSB induction, resection in myo3D Myo5-AID appeared to be greatly inhibited within an hour of degrading Myo5 (Fig. 5E). Together these data suggests that Arp2/3 and type-I myosins have a role both in the initiation of resection and in its maintenance.
Changes in resection lower the mobility of DSBs
Since resection was affected by changes in Arp2/3 activity, we asked whether there was a correlation between the rate of resection and DSB mobility. Previously we and others have shown that a deletion of the chromatin remodeler FUN30 greatly reduced Exo1 and Sgs1/Dna2-dependent long-range resection [31–33]. Although resection through the 0.7 kb site was not affected in fun30∆, long-range resection past the 5 and 10 kb sites was markedly reduced (Fig. 6A). MSD analysis of a DSB showed the RC of fun30D (0.5 µm) was significantly lower than the WT (0.8 µm) (Fig. 6B-C, Table S1).
Long-range resection requires both the exonuclease Exo1 and the helicase/endonuclease DNA2-Top3-Rmi1-Sgs1 complex [34, 35]. Since the rate of resection is not affected by deleting either EXO1 or SGS1 alone [33], we blocked long range resection by deleting EXO1 and degrading Dna2-AID. There was no difference in DSB mobility between the wildtype and exo1D Dna2-AID, but when IAA was added 2 h after DSB induction the mobility of the DSB measured at 3 h was reduced: Rc WT (0.8 µm), exo1Δ DNA2-AID (0.8 µm), and exo1Δ DNA2-AID + IAA (0.5 µm). (Fig. 6D-E, Table S1).
To test whether increasing resection affected DSB mobility, we measured mobility in a strain with a second copy of EXO1 expressed under control of a galactose promoter (pGal:EXO1) at the LEU2 locus [36]. We found that there was no difference between the Rc in WT and when Exo1 was overexpressed (Fig. 6F, H and Table S1) even though the rate of resection was increased (Fig. 6I). However, pGal::EXO1 suppressed the reduction in Rc from CK-666 (Fig. 6F-H, Table S1), but did not rescue Ddc2-GFP focus formation in cells treated with CK-666 before DSB induction (Figure S5D). Taken together, continuous resection is required for the high mobility of DSBs and overexpression of Exo1 can overcome the reduced rate of resection caused by CK-666 but could not prevent the block to the initiation of resection.
Activation of the TM checkpoint in response to blocking Arp2/3 activity
When a DSB is detected, the DNA damage checkpoint (DDC) is activated to halt cell cycle progression and allow cells a chance to repair the DSB before proceeding through mitosis [37, 38]. In budding yeast, activation of the DDC is mainly controlled through the effector kinase Mec1ATR with a minor contribution by the Tel1ATM kinase [39–42]. Mec1 is recruited to DSBs by its binding partner Ddc2ATRIP, which binds to RPA loaded on ssDNA [43, 44]. Arrest by the DDC is typically monitored by cell morphology, as cells shift towards a large-budded G2/M state, and by Western blot analysis of phosphorylation of the Mec1/Tel1 target, Rad53 [45].
We hypothesized that preventing resection - by blocking Arp2/3 activity prior to HO induction - should interfere with cell cycle arrest through the DDC. Typically, a cell with a single irreparable DSB will arrest for 12–15 h before escaping arrest through a process known as adaptation [46]. Here we find that when Arp2/3 activity was blocked before DSB induction, either by drug treatment with CK-666 or degradation of Las17-AID with IAA (Fig. 7A), G2/M arrest was shortened to 4 h (Fig. 7D-G). Deletion of either Myo3 or Myo5 did not shorten checkpoint arrest (Fig. 7D-E).
While Mec1 is primarily responsible for checkpoint arrest by the DNA damage checkpoint, the Tel1-Mre11 (TM) checkpoint is an alternative checkpoint response in response to a DSB, notably in mec1D cells in which initial resection by the Mre11 complex is impaired [47]. We confirmed that the short checkpoint response we observed was attributable to the TM checkpoint, as tel1D and mre11D strains treated with CK-666 before DSB induction did not exhibit a checkpoint response (Fig. 7B-C). A mre11Δ Las17-AID double mutant treated with auxin also showed little or no G2/M arrest and western blot analysis showed that Rad53 was not phosphorylated (Fig. 7H-I).
Since degrading Las17 after DSB induction impaired further resection, we assayed whether Arp2/3 is required to maintain checkpoint arrest by adding CK-666 to our wildtype strain or IAA to Las17-AID 2 h after adding galactose and monitored for changes in cell morphology (Fig. 7A). We found that treatment with CK-666 or degrading Las17-AID resulted in cells escaping G2/M arrest early despite Rad53 remaining hyperphosphorylated (Fig. 7J-K). These results show that the shortened DSB-induced checkpoint arrest was dependent on the TM checkpoint which was activated when resection was impaired by inhibiting Arp2/3 or its associated factors.
DSB Mobility and Repair by Gene Conversion
If DSB-induced chromatin mobility facilitates homology search, then lowering the mobility of DSBs might impact the repair efficiency carried out by gene conversion (GC). To study how changes in chromatin mobility affect the efficiency of DSB repair, we modified the well-characterized strain YJK17 which has an ectopic, mutated copy of MAT (MATa-inc) that cannot be cut by the HO-endonuclease and which serves as a donor to repair the cleavage at MATα by interchromosomal gene conversion (Fig. 8A) [33, 48]. With this strain we could generate and monitor the repair of a single DSB event.
Deletion of MYO3, MYO5, or MRE11 did not impact repair; however Las17-AID showed a significant decrease in viability from YP-Gal (79%) and YP-Gal + IAA (46%) plates (Fig. 8B). An mre11Δ Las17-AID double mutant showed an even more significant drop in viability (65% on YP-Gal and 10% on YP-Gal + IAA) (Fig. 8B). Las17-AID survivors from the YP-Gal and YP-Gal + IAA plates grew normally on YPD and YP-Gal plates (Figure S7) as expected.
To further test the effects of mobility-deficient mutants on GC, we deleted MYO5 and modified Las17 in a series of strains we had previously characterized with repair efficiencies ranging from 46–9% [49]. The differences in repair efficiencies reflect the contact probability between the DSB site and the LEU2 donor sequence. As with YJK17, we found that myo5D did not affect repair efficiency (Fig. 8D) but Las17-AID + IAA showed a significant decrease in the percentage of survivors in all 4 strains (Fig. 8E).
Since degradation of Las17 showed reduced resection, we wanted to know how this would affect repair by single-strand annealing (SSA) using the previously characterized strain YMV2, which has an HO cut-site inserted in LEU2 on chromosome 3 (leu2-cs) and a 1.3 kb fragment of the 3’ end of LEU2 (U2) inserted 30 kb upstream of leu2-cs (Fig. 8F) [50]. The DSB can be repaired both by Rad51-dependent break-induced replication and by Rad51-independent SSA [33]. Degradation of Las17 reduced the survival rate from 86–63% (Fig. 8G). Deletion of RAD51 did not affect the repair efficiency, 85% (Fig. 8G). Yet when Las17 was degraded in the rad51Δ background, repair efficiency dropped to 36% (Fig. 8G). This suggests that Las17 and Arp2/3 have a role in repair by SSA and have much less effect on BIR, where much less resection is required.